PHARMACOGENETICS DIAGNOSTIC LABORATORIES

Basic Information

201 E. JEFFERSON STREET
Suite 309
LOUISVILLE, KY, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 135412190
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of a Personalized Medicine Interface for the Safe and Effective Treat

    Amount: $3,066,677.00

    DESCRIPTION (provided by applicant):     Improvements in the safety and efficacy of warfarin therapy will result from intelligent application of knowledge derived from inherited ch ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. Development of a Personalized Medicine Interface for the Safe and Effective Treat

    Amount: $1,394,314.00

    DESCRIPTION (provided by applicant): Warfarin is the most commonly used oral anticoagulant medication. Because an individual's proper warfarin dose is difficult to assess, most physicians initiate th ...

    SBIR Phase II 2008 Department of Health and Human Services
  3. Development of a Personalized Medicine Interface for the Safe and Effective Treat

    Amount: $115,534.00

    DESCRIPTION (provided by applicant): PGXL Laboratories has access to a unique computational tool that can significantly reduce the morbidity and mortality associated with warfarin anticoagulation the ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government